Clinical experience with a low-dose fixed. Combination of perindopril-indapamide in a hypertensive population with diabetes. Data from the pretendiabetes study

被引：0
|
作者：
Barrios, V. [1 ]
Escobar, C. [1 ]
Divison, J. A. [2 ]
Medialdea, F. [3 ]
机构：
[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[2] CS Casa Ibanez, Primary Care, Albacete, Spain
[3] Servier, Dept Med, Madrid, Spain
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [31] Assessment of antihypertensive efficacy of first-line low-dose combination perindopril/indapamide (Noliprel) depending on concomitant risk factors in NOTA study
    Netchessova, T.
    Lollini, V.
    Mitkovskaya, N.
    Dolgoshei, T.
    Stankevich, F.
    Zhdanov, A.
    JOURNAL OF HYPERTENSION, 2008, 26 : S478 - S479
  • [32] Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study
    Vlachopoulos, C.
    Grammatikou, V.
    Kallistratos, M.
    Karagiannis, A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (09) : 1605 - 1610
  • [33] Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients:: the PICXEL study rationale and design
    Gosse, P
    Dubourg, O
    Guéret, P
    De Simone, G
    Schmieder, R
    De Leeuw, PW
    Degaute, JP
    Puig, JG
    Karpov, Y
    Magometschnigg, D
    Matos, L
    Amouyel, P
    Asmar, R
    Le Heuzey, JY
    Nieminen, M
    Dahlöf, B
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (09) : 653 - 659
  • [34] Treatment based on a very low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive Type 2 diabetic patients: the PREMIER study
    Viberti, G
    Mogensen, C
    Ritz, E
    Halimi, S
    Ruilope, L
    Jermendy, G
    Widimsky, J
    Sareli, P
    Taton, J
    Erdogan, G
    Rull, J
    DIABETOLOGIA, 2002, 45 : A65 - A66
  • [35] Efficacy over 1 year of a fixed low-dose combination of perindopril 2 mg indapamide 0.625 mg in the treatment of isolated systolic hypertension in subjects aged over 65 years
    Chalmers, J
    Castaigne, A
    Chastang, C
    Feldmann, L
    Guez, D
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 139A - 139A
  • [36] Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/ Indapamide, and Telmisartan/Amlodipine/ Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study
    Samajdar, Shambo samrat
    Mukherjee, Shatavisa
    Tripathi, Santanu Kumar
    Pal, Jyotirmoy
    Joshi, Shashank
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : OC22 - OC25
  • [37] EFFECTIVENESS, ADHERENCE AND TOLERABILITY OF PERINDOPRIL/AMLODIPINE FIXED DOSE COMBINATION, IN DAILY CLINICAL PRACTICE. RESULTS FROM THE EMERALD STUDY
    Vlachopoulos, C.
    Grammatikou, V.
    Kallistratos, M.
    Karagiannis, A.
    JOURNAL OF HYPERTENSION, 2015, 33 : E196 - E197
  • [38] DIFFERENCES IN CLINICAL PROFILE, BLOOD PRESSURE CONTROL RATES AND THERAPEUTIC APPROACH ACCORDING TO GENDER IN A HYPERTENSIVE POPULATION WITH DIABETES. DATA FROM PRESCAP STUDY
    Rodriguez-Roca, G. C.
    Llisterri, J. L.
    Alonso, F. J.
    Escobar, C.
    Perez, M. A.
    Beato, P.
    Artigao, L. M.
    Prieto, M. A.
    Genique, R.
    Garcia, O.
    Gonzalez-Segura, D.
    JOURNAL OF HYPERTENSION, 2010, 28 : E141 - E141
  • [39] COMBINED THERAPY OF ARTERIAL HYPERTENSION WITH TRIPLE FIXED-DOSE COMBINATION OF AMLODIPINE/INDAPAMIDE/PERINDOPRIL ARGININE IN REAL CLINICAL PRACTICE: THE ORGANIZATION AND THE MAIN RESULTS OF THE DOKAZATEL'STVO (PROOF) STUDY
    Kobalava, Zh. D.
    Troitskaya, E. A.
    Tolkacheva, V. V.
    KARDIOLOGIYA, 2018, 58 (09) : 21 - 30
  • [40] Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design
    P Gosse
    O Dubourg
    P Guéret
    G De Simone
    R Schmieder
    P W De Leeuw
    J-P Degaute
    J García Puig
    Y Karpov
    D Magometschnigg
    L Matos
    P Amouyel
    R Asmar
    J-Y Le Heuzey
    M Nieminen
    B Dahlöf
    Journal of Human Hypertension, 2002, 16 : 653 - 659
12345